T-cell lymphoblastic lymphoma in constitutional mismatch repair deficiency (CMMRD): Exploring treatment opportunities

Hemasphere. 2024 May 12;8(5):e73. doi: 10.1002/hem3.73. eCollection 2024 May.

Authors

Emma Kroeze¹, Dilys D Weijers¹, Michelle M Kleisman¹, Uri Ilan¹, Reno S Bladergroen¹, Rico Hagelaar^{1

2}, Jules P P Meijerink^{1

3}, Marjolijn C J Jongmans^{1

4}, Jan L C Loeffen¹, Roland P Kuiper^{1

4}

Affiliations

¹ Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.
² Oncode Institute Utrecht The Netherlands.
³ Present address: Acerta-Pharma (AstraZeneca) Oss The Netherlands.
⁴ Department of Genetics, Utrecht University Medical Center Utrecht University Utrecht The Netherlands.

No abstract available